Compare Danaher Corporation (DHR) vs ServiceNow Inc (NOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs ServiceNow Inc — how do they compare? Danaher Corporation trades at $197.72 (market cap $140.88B), while ServiceNow Inc trades at $105.84 (market cap $108.13B). The key difference: Danaher Corporation is the larger of the two by market cap, and Danaher Corporation pays a 0.8% dividend while ServiceNow Inc pays none. Which is the better fit depends on your goals.
| DHR | NOW | |
|---|---|---|
Market Cap | $140.88B | $108.13B |
Sector | Health | Technology |
52-Week High | $242.05 | $199.24 |
52-Week Low | $161.91 | $83.00 |
Enterprise Value | $153.66B | $105.38B |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.
The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.
ServiceNow (NOW) trades at $104.85, down 2.66% on the day, amid a generally bullish technical and fundamental backdrop. The stock exhibits strong revenue growth, with 2025 revenue reaching $13.28B and a robust net income margin of 12.59%. Analyst sentiment is overwhelmingly positive, with an 85.51% buy rating and a consensus price target of $137.96, suggesting significant upside potential. Recent news highlights the company's positioning as an 'AI control tower,' with strong performance in May.
The outlook for NOW is favorable, driven by AI adoption and consistent earnings beats, though high valuation multiples (P/E of 66.23) pose a risk if growth slows. Key investment opportunities include expanding profit margins and market share in enterprise software, while risks involve competitive pressures and execution challenges in a high-interest-rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About ServiceNow Inc
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →
